175 related articles for article (PubMed ID: 36376331)
1. Multi-omics HeCaToS dataset of repeated dose toxicity for cardiotoxic & hepatotoxic compounds.
Verheijen M; Sarkans U; Wolski W; Jennen D; Caiment F; Kleinjans J;
Sci Data; 2022 Nov; 9(1):699. PubMed ID: 36376331
[TBL] [Abstract][Full Text] [Related]
2. Epirubicin Alters DNA Methylation Profiles Related to Cardiotoxicity.
Nguyen N; Lienhard M; Herwig R; Kleinjans J; Jennen D
Front Biosci (Landmark Ed); 2022 Jun; 27(6):173. PubMed ID: 35748249
[TBL] [Abstract][Full Text] [Related]
3. Bringing in vitro analysis closer to in vivo: Studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling.
Verheijen M; Schrooders Y; Gmuender H; Nudischer R; Clayton O; Hynes J; Niederer S; Cordes H; Kuepfer L; Kleinjans J; Caiment F
Toxicol Lett; 2018 Sep; 294():184-192. PubMed ID: 29803840
[TBL] [Abstract][Full Text] [Related]
4. Application of radiation omics in the development of adverse outcome pathway networks: an example of radiation-induced cardiovascular disease.
Azimzadeh O; Moertl S; Ramadan R; Baselet B; Laiakis EC; Sebastian S; Beaton D; Hartikainen JM; Kaiser JC; Beheshti A; Salomaa S; Chauhan V; Hamada N
Int J Radiat Biol; 2022; 98(12):1722-1751. PubMed ID: 35976069
[TBL] [Abstract][Full Text] [Related]
5. Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases.
Sun YV; Hu YJ
Adv Genet; 2016; 93():147-90. PubMed ID: 26915271
[TBL] [Abstract][Full Text] [Related]
6. Prediction of oral hepatotoxic dose of natural products derived from traditional Chinese medicines based on SVM classifier and PBPK modeling.
Li S; Yu Y; Bian X; Yao L; Li M; Lou YR; Yuan J; Lin HS; Liu L; Han B; Xiang X
Arch Toxicol; 2021 May; 95(5):1683-1701. PubMed ID: 33713150
[TBL] [Abstract][Full Text] [Related]
7. [Multi-omics technology and its applications to life sciences: a review].
Liu J; Li W; Wang L; Li J; Li E; Luo Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3581-3593. PubMed ID: 36305394
[TBL] [Abstract][Full Text] [Related]
8. Research progress of omics technology in the field of tumor resistance: From single
Sun Z; Liu Y; Ouyang Q; Liu Z; Liu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 46(6):620-627. PubMed ID: 34275931
[TBL] [Abstract][Full Text] [Related]
9. Network integration and modelling of dynamic drug responses at multi-omics levels.
Selevsek N; Caiment F; Nudischer R; Gmuender H; Agarkova I; Atkinson FL; Bachmann I; Baier V; Barel G; Bauer C; Boerno S; Bosc N; Clayton O; Cordes H; Deeb S; Gotta S; Guye P; Hersey A; Hunter FMI; Kunz L; Lewalle A; Lienhard M; Merken J; Minguet J; Oliveira B; Pluess C; Sarkans U; Schrooders Y; Schuchhardt J; Smit I; Thiel C; Timmermann B; Verheijen M; Wittenberger T; Wolski W; Zerck A; Heymans S; Kuepfer L; Roth A; Schlapbach R; Niederer S; Herwig R; Kleinjans J
Commun Biol; 2020 Oct; 3(1):573. PubMed ID: 33060801
[TBL] [Abstract][Full Text] [Related]
10. Unveiling the mechanism of action of nature-inspired anti-cancer compounds using a multi-omics approach.
Soares NC; Ali A; Srinivasulu V; Sharaf BM; Giddey AD; Okendo J; Al-Hroub HM; Semreen MH; Hamad M; Al-Tel TH
J Proteomics; 2022 Aug; 265():104660. PubMed ID: 35728772
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity of cyclophosphamide's metabolites: an in vitro metabolomics approach in AC16 human cardiomyocytes.
Dionísio F; Araújo AM; Duarte-Araújo M; Bastos ML; Guedes de Pinho P; Carvalho F; Costa VM
Arch Toxicol; 2022 Feb; 96(2):653-671. PubMed ID: 35088106
[TBL] [Abstract][Full Text] [Related]
12. The enhanced value of combining conventional and "omics" analyses in early assessment of drug-induced hepatobiliary injury.
Ellinger-Ziegelbauer H; Adler M; Amberg A; Brandenburg A; Callanan JJ; Connor S; Fountoulakis M; Gmuender H; Gruhler A; Hewitt P; Hodson M; Matheis KA; McCarthy D; Raschke M; Riefke B; Schmitt CS; Sieber M; Sposny A; Suter L; Sweatman B; Mally A
Toxicol Appl Pharmacol; 2011 Apr; 252(2):97-111. PubMed ID: 20888850
[TBL] [Abstract][Full Text] [Related]
13. A Multi-Omics Common Data Model for Primary Immunodeficiencies.
Buy M; Digan W; Chen X; Husson J; Ménager M; Rieux-Laucat F; Garcelon N;
Stud Health Technol Inform; 2022 Jun; 290():56-60. PubMed ID: 35672970
[TBL] [Abstract][Full Text] [Related]
14. Single-Cell Multi-Omics and Its Prospective Application in Cancer Biology.
Peng A; Mao X; Zhong J; Fan S; Hu Y
Proteomics; 2020 Jul; 20(13):e1900271. PubMed ID: 32223079
[TBL] [Abstract][Full Text] [Related]
15. Aging Atlas: a multi-omics database for aging biology.
Aging Atlas Consortium
Nucleic Acids Res; 2021 Jan; 49(D1):D825-D830. PubMed ID: 33119753
[TBL] [Abstract][Full Text] [Related]
16. Translational Proteomics Analysis of Anthracycline-Induced Cardiotoxicity From Cardiac Microtissues to Human Heart Biopsies.
Nguyen N; Souza T; Verheijen MCT; Gmuender H; Selevsek N; Schlapbach R; Kleinjans J; Jennen D
Front Genet; 2021; 12():695625. PubMed ID: 34211507
[TBL] [Abstract][Full Text] [Related]
17. Applications of Omics Technologies for Three-Dimensional
Pieters VM; Co IL; Wu NC; McGuigan AP
Tissue Eng Part C Methods; 2021 Mar; 27(3):183-199. PubMed ID: 33406987
[TBL] [Abstract][Full Text] [Related]
18. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
19. Expression Profiling of Human Pluripotent Stem Cell-Derived Cardiomyocytes Exposed to Doxorubicin-Integration and Visualization of Multi-Omics Data.
Holmgren G; Sartipy P; Andersson CX; Lindahl A; Synnergren J
Toxicol Sci; 2018 May; 163(1):182-195. PubMed ID: 29385562
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
